NCT06290102: Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old |
|
|
| Recruiting | 1 | 22 | US | TEV-56248, - fluticasone propionate/albuterol sulfate multidose dry powder inhaler with e-module (Fp/ABS eMDPI), Fp MDPI, - fluticasone propionate multidose dry powder inhaler | Teva Branded Pharmaceutical Products R&D, Inc. | Asthma | 10/24 | 11/24 | | |
